Response to first intravenous steroid therapy Determines the Subsequent risk of colectomy in ulcerative colitis patients

Journal of Gastrointestinal and Liver Diseases

Volumn 20, Issue 4, 2011, Pages 359-363

  Molnár, Tamás ^a   Farkas, Klaudia ^a   Nyári, Tibor ^a   Szepes, Zoltán ^a   Nagy, Ferenc ^a   Wittmann, Tibor ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Acute ulcerative colitis intravenous corticosteroids colectomy rate

Indexed keywords

6 MERCAPTOPURINE DERIVATIVE; AMINOSALICYLIC ACID DERIVATIVE; AZATHIOPRINE; CALCINEURIN INHIBITOR; CORTICOSTEROID; CYCLOSPORIN; INFLIXIMAB; METHYLPREDNISOLONE;

ADOLESCENT; ADULT; AGED; ANEMIA; ARTICLE; BLOOD TRANSFUSION; COLON RESECTION; CORTICOSTEROID THERAPY; DISEASE EXACERBATION; FEMALE; FOLLOW UP; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTOR VARIABLE; TREATMENT INDICATION; TREATMENT RESPONSE; ULCERATIVE COLITIS; UNSPECIFIED SIDE EFFECT;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; AGED; CHI-SQUARE DISTRIBUTION; CHILD; COLECTOMY; COLITIS, ULCERATIVE; DISEASE-FREE SURVIVAL; DRUG ADMINISTRATION ROUTES; FEMALE; HOSPITALIZATION; HUMANS; HUNGARY; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84055222276     PISSN: 18418724     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Moss AC, Peppercorn MA. Steroid-refractory severe ulcerative colitis: what are the available treatment options? Drugs 2008; 68: 1157-1167.
2. Travis SP, Stange EF, Lémann M, et al. European evidence-based Consensus on the management of ulcerative colitis: Current management. J Crohns Colitis 2008; 2: 24-62.
3. Hefti MM, Chessin DB, Harpaz NH, Steinhagen RM, Ullman TA. Severity of inflammation as a predictor of colectomy in patients with chronic ulcerative colitis. Dis Colon Rectum 2009; 52: 193-197.
4. Ananthakrishnan AN, Issa M, Beaulieu DB, et al. History of medical hospitalization predicts future need for colectomy in patients with ulcerative colitis. Inflamm Bowel Dis 2009: 15: 176-181.
5. Bojic D, Radojicic Z, Nedeljkovic-Protic M, Al-Ali M, Jewell DP, Travis SP. Long-term outcome after admission for acute severe ulcerative colitis in Oxford: The 1992-1993 Cohort. Inflamm Bowel Dis 2009; 15: 823-828.
6. Travis SP, Farrant JM, Ricketts C, et al. Predicting outcome in severe ulcerative colitis. Gut 1996; 38: 905-910.
7. Stange EF, Travis SP, Vermeire S, et al. European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis. J Crohns Colitis 2008; 2: 1-23.
8. Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5- aminosalicylic acid therapy for mildly to moderately active ulcerative colitis: a randomized study. N Engl J Med 1987; 317: 1625-1629.
9. Truelove SC, Witts LJ. Cortisone in ulcerative colitis; final report on a therapeutic trial. Br Med J 1955; 2:1041-1048.
10. Turner D, Kolho KJ, Mack DR, et al. Glucocorticoid bioactivity does not predict response to steroid therapy in severe pediatric ulcerative colitis. Inflamm Bowel Dis 2010; 16: 469-473.
11. Daperno M, Sostegni R, Scaglione N, et al. Outcome of a conservative approach in severe ulcerative colitis. Dig Liver Dis 2004; 36: 21-28.
12. Bernal I, Manosa M, Domenech E, et al. Predictors of clinical response to systemic steroids in active ulcerative colitis. Dig Dis Sci 2006; 51: 1434-1438.
13. Randall J, Singh B, Warren BF, Travis SP, Mortensen NJ, George BD. Delayed surgery for acute severe ulcerative colitis is associated with increased risk of postoperative complications. Br J Surg 2010; 97: 404-409.
14. Turner D, Walsh CM, Steinhart AH, Griffiths AM. Response to corticosteroids in severe ulcerative colitis: a systematic review of the literature and a meta-regression. Clin Gastroenterol Hepatol 2007; 5: 103-110.